Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,578 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Central nervous system relapse after allogeneic HCT in FLT3-mutated AML.
Kouidri K, Acker F, Toenges R, Pfaff S, Lindner S, Riemann J, Werth M, Ajib S, Lang F, Steffen B, Oellerich T, Serve H, Cremer A, Bug G. Kouidri K, et al. Among authors: lang f. Ann Hematol. 2024 Nov 26. doi: 10.1007/s00277-024-06106-y. Online ahead of print. Ann Hematol. 2024. PMID: 39589497
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML.
Cremer A, Enssle JC, Pfaff S, Kouidri K, Lang F, Brandts C, Zeiher A, Cremer S, Steffen B, Serve H, Bug G. Cremer A, et al. Among authors: lang f. Ann Hematol. 2023 Oct;102(10):2903-2908. doi: 10.1007/s00277-023-05396-y. Epub 2023 Aug 8. Ann Hematol. 2023. PMID: 37552323 Free PMC article. Review.
Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of antibiotic administration.
Toenges R, Lang F, Ghaffar R, Lindner S, Schlipfenbacher V, Riemann J, Ajib S, Kouidri K, Cremer A, Weber B, Nguyen NTT, Knoch A, Vehreschild J, Serve H, Bug G. Toenges R, et al. Among authors: lang f. Ann Hematol. 2024 Nov;103(11):4687-4699. doi: 10.1007/s00277-024-05986-4. Epub 2024 Sep 6. Ann Hematol. 2024. PMID: 39237814
A Multicentre, Randomized Trial in Adults with de novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia to Assess the Efficacy of Ponatinib versus Imatinib in Combination with Low-Intensity Chemotherapy, to Compare End of Therapy with Indication for Stem Cell Transplantation versus Tyrosine Kinase Inhibitor, Blinatumomab, and Chemotherapy in Optimal Responders, and to Evaluate Blinatumomab in Suboptimal Responders (GMALL-EVOLVE).
Lang F, Pfeifer H, Brüggemann M, Hermann E, Serve H, Goekbuget N. Lang F, et al. Oncol Res Treat. 2024;47(9):430-433. doi: 10.1159/000539391. Epub 2024 May 16. Oncol Res Treat. 2024. PMID: 38754400 Free PMC article. Clinical Trial.
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
Stelljes M, Middeke JM, Bug G, Wagner-Drouet EM, Müller LP, Schmid C, Krause SW, Bethge W, Jost E, Platzbecker U, Klein SA, Schubert J, Niederland J, Kaufmann M, Schäfer-Eckart K, Schaich M, Baldauf H, Stölzel F, Petzold C, Röllig C, Alakel N, Steffen B, Hauptrock B, Schliemann C, Sockel K, Lang F, Kriege O, Schaffrath J, Reicherts C, Berdel WE, Serve H, Ehninger G, Schmidt AH, Bornhäuser M, Mikesch JH, Schetelig J; Study Alliance Leukemia and the German Cooperative Transplant Study Group. Stelljes M, et al. Among authors: lang f. Lancet Haematol. 2024 May;11(5):e324-e335. doi: 10.1016/S2352-3026(24)00065-6. Epub 2024 Apr 4. Lancet Haematol. 2024. PMID: 38583455 Free article. Clinical Trial.
2,578 results